Health & Fitness
Somaxon Pharmaceuticals to Present at the Jefferies 2011 Global Healthcare Conference
SAN DIEGO--([ BUSINESS WIRE ])--Somaxon Pharmaceuticals, Inc. (NASDAQ: SOMX), a specialty pharmaceutical company, today announced that Richard W. Pascoe, Somaxona™s president and chief executive officer will present at the Jefferies 2011 Global Healthcare Conference at The Grand Hyatt Hotel in New York City on Monday, June 6, at 9:00 a.m. Eastern Time.
A live webcast of the presentation will be available in the Investor Relations section of the companya™s website under Event Scheduler at [ www.somaxon.com ]. The webcast will be archived and accessible for 90 days following the conference.
To be added to Somaxon Pharmaceuticalsa™ email list, please visit [ http://bit.ly/Somaxon-email-list ].
About Somaxon Pharmaceuticals, Inc.
Headquartered in San Diego, CA, Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates to treat important medical conditions where there is an unmet medical need and/or high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Somaxona™s product Silenor®, now available by prescription in the United States, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance.
For more information, please visit the companya™s web site at [ www.somaxon.com ].
